Fibroblast RNA and macrophage proteins (including the fibrogenic factor) in experimental silicosis.

por Kulonen, E, Aalto, M, Aho, S, Lehtinen, P, Potila, M
Publicado 1983

Baseline psychosocial predictors of survival in localised breast cancer

por Lehto, U-S, Ojanen, M, Dyba, T, Aromaa, A, Kellokumpu-Lehtinen, P
Publicado 2006

Bacterial coinfections in children with viral wheezing

por Lehtinen, P., Jartti, T., Virkki, R., Vuorinen, T., Leinonen, M., Peltola, V., Ruohola, A., Ruuskanen, O.
Publicado 2006

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma

por Kallio, J P, Hirvikoski, P, Helin, H, Kellokumpu-Lehtinen, P, Luukkaala, T, Tammela, T L J, Martikainen, P M
Publicado 2003

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

por Vehmanen, L., Sievänen, H., Kellokumpu-Lehtinen, P., Nikander, R., Huovinen, R., Ruohola, J., Penttinen, H.M., Utriainen, M., Tokola, K., Blomqvist, C., Saarto, T.
Publicado 2020

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

por Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Wigren, T., Pyrhönen, S., Turpeenniemi-Hujanen, T., Asola, R., Leinonen, M., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P.
Publicado 2010

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

por Chan, A, Martin, M, Untch, M, Gil, M G, Guillem-Porta, V, Wojtukiewicz, M, Kellokumpu-Lehtinen, P, Sommer, H L, Georgoulias, V, Battelli, N, Pawlicki, M, Aubert, D, Bourlard, T, Gasmi, J, Villanova, G, Petruzelka, L
Publicado 2006